Your browser doesn't support javascript.
Шоу: 20 | 50 | 100
Результаты 1 - 2 de 2
Фильтр
Добавить фильтры

база данных
Годовой диапазон
1.
Prague Med Rep ; 124(1): 33-39, 2023.
Статья в английский | MEDLINE | ID: covidwho-2244891

Реферат

It has been recommended that patients with leukaemias and lymphomas undergo universal screening for SARS-COV-2 using RT-qPCR before each treatment on the grounds of their high risk of experiencing severe forms of COVID-19. This raises a conflict with different recommendations which prioritise testing symptomatic patients. We found that among 56 RT-qPCR obtained in asymptomatic patients with hematologic neoplasms before chemotherapy administration, 2 (3.5%) were positive. A negative result did not exclude SARS-COV-2 infection in 1 patient (1.8%). It is unclear what the benefit of screening for SARS-COV-2 using RT-qPCR in patients with hematologic neoplasms who receive chemotherapy is.


Тема - темы
COVID-19 , Hematologic Neoplasms , Leukemia , Humans , SARS-CoV-2 , COVID-19/diagnosis , COVID-19 Testing , Hematologic Neoplasms/diagnosis , Hematologic Neoplasms/drug therapy , Hematologic Neoplasms/genetics , Sensitivity and Specificity
2.
Prague Med Rep ; 123(4): 250-257, 2022.
Статья в английский | MEDLINE | ID: covidwho-2145507

Реферат

The SARS-CoV-2 viral load in a respiratory sample can be inversely quantified using the cycle threshold (Ct), defined as the number of amplification cycles required to detect the viral genome in a quantitative PCR assay using reverse transcriptase (RT-qPCR). It may be classified as high (Ct < 25), intermediate (25-30) and low (Ct > 30). We describe the clinical course of 3 patients with haematological neoplasms who contracted COVID-19. None of them had been vaccinated. Firstly, a 22-year-old male with a refractory acute lymphoblastic leukaemia experienced an oligosymptomatic COVID-19 and had a Ct of 23 with an ascending curve. Another male, aged 23, had recently begun treatment for a promyelocytic leukaemia. He had a subacute course with high oxygen requirements. His Ct dropped from 28, when he only experienced fever, to 14.8, during the most critical period and on the edge of ventilatory support. Viral clearance was documented 126 days after the beginning of the symptoms. Finally, a 60-year-old male had received rituximab as maintenance therapy for a follicular lymphoma 3 months before contracting COVID-19. He had a fulminant course and required mechanical ventilation a few days later. We highlight the association between the course of CoViD-19 and the Ct. Viral shedding was longer than in immunocompetent hosts.


Тема - темы
COVID-19 , Hematologic Neoplasms , Neoplasms , Humans , Male , Young Adult , Adult , Middle Aged , RNA, Viral/analysis , RNA, Viral/genetics , SARS-CoV-2 , Hematologic Neoplasms/complications
Критерии поиска